On December 9, Gelonghui reported that Chengda Pharmaceutical (301201.SZ) recently stated in an investor relations activity that the company's L-carnitine series products are exported to over 30 countries globally, with stable quality and a good international reputation, making it one of the main suppliers of L-carnitine worldwide. Currently, the sales prices of the company's L-carnitine products are relatively stable, having slightly improved from the lowest market prices, but there remains a certain level of uncertainty regarding the future price trend of related products.
诚达药业(301201.SZ)：左旋肉碱系列产品出口全球30多个国家，品质稳定
Chengda Pharmaceutical (301201.SZ): The L-carnitine series products are exported to over 30 global countries, with stable quality.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Investment Course
Choose stocks based on financial reports
Quickly master financial season learning guidelines
When the financial season comes, company stock prices are the most likely to rise and fall, and many excellent investors will see the financial season as a good
In 【2024.11】, surged more than 0.04 million times, achieving the title of stock god Buffett! How do you view Berkshire's performance?
When it comes to legendary figures in the investment world, the name of Warren Buffett, the helm of Berkshire Hathaway, is definitely unavoidable. $Berkshire Ha
【November 2024】Has disney's predicament turned around? Pay attention to these 3 performance signals.
As the entertainment kingdom for nearly a century, Disney's status in Hollywood has gained prominence. Over 60 years of listing on the U.S. stock market, Disney